 0 Table of Contents |
  1 Home |
  2 Home (en) |
  3 Architektur |
  4 Architecture |
  5 Dateiformate |
  6 File Formats |
  7 Quickstart (de) |
  8 Quickstart (en) |
  9 Setup (de) |
  10 Setup (en) |
  11 Support (de) |
  12 Support (en) |
  13 Technische Dokumentation |
  14 Technical Documentation |
  15 UI Features (de) |
  16 UI Features (en) |
  17 Wie man TerminoloGit verwendet |
  18 How to use TerminoloGit |
  19 Artifacts Summary |
   19.1 APPC_Anatomie |
   19.2 APPC_Lateralitaet |
   19.3 APPC_Modalitaet |
   19.4 APPC_Prozeduren |
   19.5 atcdabbr-LateralityQualifiercode |
   19.6 atcdabbr_NoInformationQualifier |
   19.7 Austrian Designation Use |
   19.8 DGC_Country |
   19.9 DGC_DiseaseOrAgent |
   19.10 DGC_Doses |
   19.11 DGC_MedicinalProduct |
   19.12 DGC_RATNameManufacturer |
   19.13 DGC_ResultOfTheTest |
   19.14 DGC_TypeofTest |
   19.15 DGC_Vaccine |
   19.16 DGC_VaccineMarketingAuthorizationHolder |
   19.17 DICOM_SOPClasses |
   19.18 eHDSI-Administrative-Gender |
   19.19 eHDSI-Country |
   19.20 eHDSI-DoseForm |
   19.21 eHDSI-HealthcareProfessionalRole |
   19.22 eHDSI-Package |
   19.23 eHDSI-Quantity-Unit |
   19.24 eHDSI-Route-of-Administration |
   19.25 eHDSI-Substance |
   19.26 eHDSI-Telecom-Address |
   19.27 eHDSI-Timing-Event |
   19.28 eHDSI-Unit |
   19.29 eHDSI_ActiveIngredient |
   19.30 eHDSI_ActSubstanceAdministrationCode |
   19.31 EHDSI_Confidentiality |
   19.32 EHDSI_Language |
   19.33 eImpf_Antikoerperbestimmung |
   19.34 eImpf_HistorischeImpfstoffe |
   19.35 eImpf_ImmunizationTarget |
   19.36 eImpf_Impfdosis |
   19.37 eImpf_Impfgrund |
   19.38 eImpf_ImpfrelevanteErkrankung |
   19.39 eImpf_Impfrollen |
   19.40 eImpf_Impfschema |
   19.41 eImpf_Impfstoffe |
   19.42 eImpf_KostenfreiesImpfprogramm |
   19.43 eImpf_Mengenart |
   19.44 eImpf_SpecialCaseVaccination |
   19.45 eImpf_SpecialSituationIndication |
   19.46 eImpf_Zusatzklassifikation |
   19.47 eImpf_Zusatzklassifikation_Impfprogramm |
   19.48 eImpf_Zusatzklassifikation_Impfsetting |
   19.49 ELGA Lebensmittelallergene |
   19.50 ELGA_AbsentOrUnknownAllergies |
   19.51 ELGA_AbsentOrUnknownDevices |
   19.52 ELGA_AbsentOrUnknownMedication |
   19.53 ELGA_AbsentOrUnknownProblems |
   19.54 ELGA_AbsentOrUnknownProcedures |
   19.55 ELGA_ActCode_AbgInfo |
   19.56 ELGA_ActCode_PatInfo |
   19.57 ELGA_ActEncounterCode |
   19.58 ELGA_AddressUse |
   19.59 ELGA_AdministrativeGender |
   19.60 ELGA_AlcoholConsumption |
   19.61 ELGA_AllergieTyp |
   19.62 ELGA_AllergyOrIntoleranceAgent |
   19.63 ELGA_AllergyOrIntoleranceType |
   19.64 ELGA_AllergyReaction |
   19.65 ELGA_AllergyStatusCode |
   19.66 ELGA_AnamneseLaborMikrobiologie |
   19.67 ELGA_Antibiogramm |
   19.68 ELGA_ArtderDiagnose |
   19.69 ELGA_AuditEventID |
   19.70 ELGA_AuditEventType |
   19.71 ELGA_AuditEventType_A-ARR |
   19.72 ELGA_AuditParticipantObjectIdType |
   19.73 ELGA_AuditParticipantObjectType |
   19.74 ELGA_AuditParticipantObjectTypeRole |
   19.75 ELGA_AuditRoleID |
   19.76 ELGA_AuditSourceType |
   19.77 ELGA_AuthorSpeciality |
   19.78 ELGA_ConditionStatusCode |
   19.79 ELGA_ConditionVerificationStatus |
   19.80 ELGA_Confidentiality |
   19.81 ELGA_CriticalityObservationValue |
   19.82 ELGA_CurrentSmokingStatus |
   19.83 ELGA_Diagnosesicherheit |
   19.84 ELGA_Dokumentenklassen |
   19.85 ELGA_Dosisparameter |
   19.86 ELGA_Einnahmezeitpunkte |
   19.87 ELGA_EntityNamePartQualifier |
   19.88 ELGA_EntityNameUse |
   19.89 ELGA_EntlassungsmanagementA |
   19.90 ELGA_ExpectedDeliveryDateMethod |
   19.91 ELGA_FormatCode |
   19.92 ELGA_FormatCodeZusatz |
   19.93 ELGA_HealthcareFacilityTypeCode |
   19.94 ELGA_HumanActSite |
   19.95 ELGA_HumanLanguage |
   19.96 ELGA_InformationRecipientType |
   19.97 ELGA_InsuredAssocEntity |
   19.98 ELGA_KulturErregernachweis |
   19.99 ELGA_Laborparameter |
   19.100 ELGA_Laborstruktur |
   19.101 ELGA_Laendercodes |
   19.102 ELGA_LanguageAbilityMode |
   19.103 ELGA_LanguageCode |
   19.104 ELGA_MammogramAssessment |
   19.105 ELGA_MaritalStatus |
   19.106 ELGA_MedicalDevices |
   19.107 ELGA_Medientyp |
   19.108 ELGA_MedikationAbgabeArt |
   19.109 ELGA_MedikationArtAnwendung |
   19.110 ELGA_MedikationDarreichungsform |
   19.111 ELGA_MedikationFrequenz |
   19.112 ELGA_MedikationMengenart |
   19.113 ELGA_MedikationMengenartAlternativ |
   19.114 ELGA_MedikationPharmazeutischeEmpfehlungStatus |
   19.115 ELGA_MedikationRezeptart |
   19.116 ELGA_MedikationRezeptpflichtstatus |
   19.117 ELGA_MedikationTherapieArt |
   19.118 ELGA_Mikroorganismen |
   19.119 ELGA_NachweisErgebnis |
   19.120 ELGA_NoInformation |
   19.121 ELGA_NullFlavor |
   19.122 ELGA_ObservationInterpretation |
   19.123 ELGA_ParticipationFunctionCode |
   19.124 ELGA_PersonalRelationship |
   19.125 ELGA_PracticeSetting |
   19.126 ELGA_PregnanciesSummary |
   19.127 ELGA_PregnancyStatus |
   19.128 ELGA_Probenmaterial |
   19.129 ELGA_Problemarten |
   19.130 ELGA_Problemkataloge |
   19.131 ELGA_ProblemSeverity |
   19.132 ELGA_ProblemStatusCode |
   19.133 ELGA_ProcedureApproachSite |
   19.134 ELGA_ProficiencyLevelCode |
   19.135 ELGA_Radiopharmaceuticals |
   19.136 ELGA_RealmCode |
   19.137 ELGA_ReligiousAffiliation |
   19.138 ELGA_RoleClass |
   19.139 ELGA_Rollen |
   19.140 ELGA_SectionsEntlassungAerztl |
   19.141 ELGA_SectionsEntlassungPflege |
   19.142 ELGA_SectionsPflegeSitber |
   19.143 ELGA_SectionsRadiologie |
   19.144 ELGA_SectionsServiceEvents |
   19.145 ELGA_Seitenlokalisation |
   19.146 ELGA_ServiceEventPerformer |
   19.147 ELGA_ServiceEventsEntlassbr |
   19.148 ELGA_ServiceEventsLabor |
   19.149 ELGA_ServiceEventsTelemonEpi |
   19.150 ELGA_SignificantPathogens |
   19.151 ELGA_SpecimenType |
   19.152 ELGA_TargetSite |
   19.153 ELGA_TelecomAddressUse |
   19.154 ELGA_TopographicalModifierQualifier |
   19.155 ELGA_TypeOfProblem |
   19.156 ELGA_URLScheme |
   19.157 ELGA_Vitalparameterarten |
   19.158 ELGA_Wirkstoffe_AGES |
   19.159 EMS_Anti-HCV-Immunoassay |
   19.160 EMS_Anti-HCV-Immunoblot_Assay |
   19.161 EMS_Betreuung |
   19.162 EMS_HBV_Status |
   19.163 EMS_HCV_core_Ag_Assay |
   19.164 EMS_Hospitalisierung |
   19.165 EMS_Impfstatus |
   19.166 EMS_KlinischeManifestation |
   19.167 EMS_Krankheitsmerkmale |
   19.168 EMS_LebensmittelbedingteIntoxikationen |
   19.169 EMS_MaterialMethode |
   19.170 EMS_Meldepflichtige_Krankheiten |
   19.171 EMS_Reiseland |
   19.172 EMS_Taetigkeitsbereich |
   19.173 EntityCode |
   19.174 HL7-at_ActConsentType |
   19.175 HL7-at_AdministrativeGender-FHIR-Extension |
   19.176 HL7-at_AdministrativeGender-v2 |
   19.177 HL7-at_OrganizationType |
   19.178 HL7-at_PatientIdentifier |
   19.179 HL7-at_PractitionerRole |
   19.180 HL7-at_XDS-Dokumentenklassen |
   19.181 langid-at |
   19.182 LKF_Diagnose-Art |
   19.183 LKF_Diagnose-statAuf |
   19.184 LKF_Diagnose-Typ |
   19.185 Orphanet_Rare Diseases |
   19.186 ParticipationType |
   19.187 RADS_BreastImaging |
   19.188 RADS_CoronaryArteryDisease |
   19.189 RADS_DiagnosticImagingScales |
   19.190 RADS_LiverImaging |
   19.191 RADS_ProstateImaging |
   19.192 RADS_ThyroidImaging |
   19.193 RouteOfAdministration |
   19.194 SNOMED_Rare Diseases |
   19.195 TargetAwareness |
   19.196 Zeiteinheiten |
   19.197 APPC_Anatomie |
   19.198 APPC_Lateralitaet |
   19.199 APPC_Modalitaet |
   19.200 APPC_Prozeduren |
   19.201 ASP-Liste |
   19.202 ATC deutsch (WIdO) |
   19.203 Austrian Designation Use |
   19.204 BMG Leistungskatalog Gesamt 2023 |
   19.205 BMG Leistungskatalog Gesamt 2024 |
   19.206 DCM |
   19.207 DGC_Antibody-Test |
   19.208 DGC_QR |
   19.209 DGC_RATNameManufacturer |
   19.210 DICOM_SOPClasses |
   19.211 eHDSI-Substance |
   19.212 eHDSI_EDQM_Auszug |
   19.213 EHDSI_Language |
   19.214 eImpf_Ergaenzung |
   19.215 eImpf_HistorischeImpfstoffe |
   19.216 eImpf_Impfstoffe |
   19.217 eImpf_Schemamatrix |
   19.218 eImpf_Zuordnungsmatrix |
   19.219 ELGA-Lebensmittelallergene |
   19.220 ELGA_ActCode |
   19.221 ELGA_AllergieTyp |
   19.222 ELGA_AuditEventID |
   19.223 ELGA_AuditEventType |
   19.224 ELGA_AuditEventTypeA-ARR |
   19.225 ELGA_AuditParticipantObjectIdType |
   19.226 ELGA_AuditParticipantObjectType |
   19.227 ELGA_AuditParticipantObjectTypeRole |
   19.228 ELGA_AuditSourceType |
   19.229 ELGA_e-Health_Anwendungen |
   19.230 ELGA_EntlassungsmanagementArt |
   19.231 ELGA_Ergaenzungsliste |
   19.232 ELGA_Fachaerzte |
   19.233 ELGA_FormatCode |
   19.234 ELGA_FormatCodeZusatz |
   19.235 ELGA_Funktionsrollen |
   19.236 ELGA_GDA_Aggregatrollen |
   19.237 ELGA_GTelVoGDARollen |
   19.238 ELGA_Kontakttypen |
   19.239 ELGA_LaborparameterErgaenzung |
   19.240 ELGA_MammogramAssessment |
   19.241 ELGA_MedikationMengenartAlternativ |
   19.242 ELGA_Patienten-Identifizierungsmethoden |
   19.243 ELGA_Pflegestufen |
   19.244 ELGA_PracticeSetting |
   19.245 ELGA_Sections |
   19.246 ELGA_ServiceEventsEntlassbrief |
   19.247 ELGA_SignificantPathogens |
   19.248 ELGA_SpecimenType_Ergaenzung |
   19.249 ELGA_URLSchemeErgaenzung |
   19.250 EMS_Analysedetails |
   19.251 EMS_AntigenH |
   19.252 EMS_AntigenO |
   19.253 EMS_ArtMalaria |
   19.254 EMS_ArtQuartier |
   19.255 EMS_Aviditaet |
   19.256 EMS_Befundart |
   19.257 EMS_Betreuung |
   19.258 EMS_Biotyp_Biovar |
   19.259 EMS_Durchgefuehrt |
   19.260 EMS_ErgaenzungMeldepflichtigeKrankheiten |
   19.261 EMS_Ergebnis |
   19.262 EMS_Genogruppe |
   19.263 EMS_Genotyp |
   19.264 EMS_GenotypPorA_R1 |
   19.265 EMS_GenotypPorA_R2 |
   19.266 EMS_Gewinnung |
   19.267 EMS_HCV_RNA |
   19.268 EMS_JaNein |
   19.269 EMS_KlinischeManifestation |
   19.270 EMS_Krankheitsmerkmale |
   19.271 EMS_ListeSchulen |
   19.272 EMS_Material |
   19.273 EMS_MaterialMethode |
   19.274 EMS_Methoden |
   19.275 EMS_MonoclonalSub |
   19.276 EMS_MultiLocSequ |
   19.277 EMS_Nachweis |
   19.278 EMS_Nachweisbar |
   19.279 EMS_Organ |
   19.280 EMS_OrtH20Probe |
   19.281 EMS_Parameter |
   19.282 EMS_Phagentyp |
   19.283 EMS_Phagentyp_VTEC |
   19.284 EMS_PosNeg |
   19.285 EMS_Quartiercode |
   19.286 EMS_Reiseland |
   19.287 EMS_Ribotype |
   19.288 EMS_Serogruppe |
   19.289 EMS_Serotyp |
   19.290 EMS_Serotyp_Gene_FetA |
   19.291 EMS_TBC_ResistenzErgaenzung |
   19.292 EMS_TBC_Resultat |
   19.293 EMS_TBC_Typ |
   19.294 EMS_TestMethodeMIC_IPD |
   19.295 EMS_TestMethodeTypingIPD |
   19.296 EMS_Verotoxin_1_Subtyp |
   19.297 EMS_Verotoxin_2_Subtyp |
   19.298 EMS_WoWurdeKrankheitErworben |
   19.299 EMS_WurdeKrankheitImportiert |
   19.300 EMS_YersinaPathogen |
   19.301 EXNDS_Concepts |
   19.302 EXNDS_FormatCodes |
   19.303 EXNDS_Metadaten |
   19.304 EXNDS_Sections |
   19.305 GDA-Org |
   19.306 GDA_Attribute |
   19.307 Geschlechtercodes - ISO IEC 5218 |
   19.308 HL7 Act Code |
   19.309 HL7 Act Site |
   19.310 HL7 ActStatus |
   19.311 HL7 Address Use |
   19.312 HL7 Administrative Gender |
   19.313 HL7 Administrative Sex |
   19.314 HL7 AT FormatCodes |
   19.315 HL7 AT ReligionAustria |
   19.316 HL7 Confidentiality Code |
   19.317 HL7 Consent Mode |
   19.318 HL7 Consent Status |
   19.319 HL7 Consent Type |
   19.320 HL7 Entity Name Part Qualifier |
   19.321 HL7 Entity Name Use |
   19.322 HL7 Konformitaet |
   19.323 HL7 Language Identification |
   19.324 HL7 LanguageAbilityMode |
   19.325 HL7 Marital Status |
   19.326 HL7 Null Flavor |
   19.327 HL7 Observation Interpretation |
   19.328 HL7 Participation Function |
   19.329 HL7 Participation Type |
   19.330 HL7 ProficiencyLevelCode |
   19.331 HL7 Role Class |
   19.332 HL7 Role Code |
   19.333 HL7 Signatory's Relationship to Subject |
   19.334 HL7 Specimen Type |
   19.335 HL7 Timing Event |
   19.336 HL7 URLScheme |
   19.337 HL7-at_AdministrativeGender-Ergaenzung |
   19.338 HL7-at_MaritalStatus-Ergaenzung |
   19.339 IANA Mime Type |
   19.340 ICD-10 BMG 2014 |
   19.341 ICD-10 BMG 2017 |
   19.342 ICD-10 BMG 2020 |
   19.343 ICD-10 BMSGPK 2022 |
   19.344 ICD-10 BMSGPK 2024+ |
   19.345 ICD-O-3 |
   19.346 ICF |
   19.347 ICPC2 |
   19.348 IHE Pharmaceutical Advice Status List |
   19.349 IPS_AbsentOrUnknownData |
   19.350 IPS_ConditionClinicalStatusCodes |
   19.351 IPS_ConditionVerificationStatus |
   19.352 ISCO |
   19.353 ISO 3166 Alpha-2-Code |
   19.354 ISO 3166-1 alpha 3 |
   19.355 ISO 639-2 |
   19.356 Leistungskatalog Ambulant |
   19.357 Leistungskatalog Gesamt |
   19.358 Leistungskatalog Stationaer |
   19.359 LKF_Diagnose-Art |
   19.360 LKF_Diagnose-statAuf |
   19.361 LKF_Diagnose-Typ |
   19.362 LKF_Ergaenzung |
   19.363 MDC_MedicalDeviceCommunications |
   19.364 MedikationRezeptart |
   19.365 MedikationTherapieart |
   19.366 Medikation_ActiveIngredient |
   19.367 Medikation_AGES_Wirkstoffe |
   19.368 Medikation_Art_Anwendung |
   19.369 Medikation_Darreichungsform |
   19.370 Medikation_Packaging |
   19.371 Medikation_Rezeptpflichtstatus |
   19.372 OEAEK_Additivfach |
   19.373 OEAEK_Berechtigungen |
   19.374 OEAEK_Fachrichtung |
   19.375 OEAEK_Spezialdiplom |
   19.376 OEAEK_Spezialisierung |
   19.377 OEAEK_Zertifikate |
   19.378 RAST-Klassen |
   19.379 Sciphox Diagnosenzusatz |
   19.380 Sciphox_Seitenlokalisation |
   19.381 SNOMED CT (Auszug) |
   19.382 UCUM |
   19.383 eImpf_Impfstoffe-Impfprogramm-Mapping |
   19.384 ELGA Lebensmittelallergene Mapping |
   19.385 SNOMED Orphanet Mapping |